Literature DB >> 31130365

Robotically-Assisted Sonic Therapy for Renal Ablation in a Live Porcine Model: Initial Preclinical Results.

Emily A Knott1, John F Swietlik2, Katherine C Longo2, Rao F Watson3, Chelsey M Green4, E Jason Abel5, Meghan G Lubner2, J Louis Hinshaw2, Amanda R Smolock6, Zhen Xu7, Fred T Lee8, Timothy J Ziemlewicz2.   

Abstract

PURPOSE: To demonstrate the feasibility of Robotically Assisted Sonic Therapy (RAST)-a noninvasive and nonthermal focused ultrasound therapy based on histotripsy-for renal ablation in a live porcine model.
MATERIALS AND METHODS: RAST ablations (n = 11) were performed in 7 female swine: 3 evaluated at 1 week (acute) and 4 evaluated at 4 weeks (chronic). Treatment groups were acute bilateral (3 swine, 6 ablations with immediate computed tomography [CT] and sacrifice); chronic single kidney (3 swine, 3 ablations; CT at day 0, week 1, and week 4 after treatment, followed by sacrifice); and chronic bilateral (1 swine, 2 ablations). Treatments were performed using a prototype system (VortxRx; HistoSonics, Inc) and targeted a 2.5-cm-diameter sphere in the lower pole of each kidney, intentionally including the central collecting system.
RESULTS: Mean treatment time was 26.4 minutes. Ablations had a mean diameter of 2.4 ± 0.3 cm, volume of 8.5 ± 2.4 cm3, and sphericity index of 1.00. Median ablation volume decreased by 96.1% over 4 weeks. Histology demonstrated complete lysis with residual blood products inside the ablation zone. Temporary collecting system obstruction by thrombus was observed in 4/11 kidneys (2 acute and 2 chronic) and resolved by 1 week. There were no urinary leaks, main vessel thromboses, or adjacent organ injuries on imaging or necropsy.
CONCLUSIONS: In this normal porcine model, renal RAST demonstrated complete histologic destruction of the target renal tissue while sparing the urothelium. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2019        PMID: 31130365      PMCID: PMC6925588          DOI: 10.1016/j.jvir.2019.01.023

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  20 in total

1.  Pulsed cavitational ultrasound therapy for controlled tissue homogenization.

Authors:  Jessica E Parsons; Charles A Cain; Gerald D Abrams; J Brian Fowlkes
Journal:  Ultrasound Med Biol       Date:  2006-01       Impact factor: 2.998

2.  Effect of Tumor Complexity and Technique on Efficacy and Complications after Percutaneous Microwave Ablation of Stage T1a Renal Cell Carcinoma: A Single-Center, Retrospective Study.

Authors:  Marki E Klapperich; E Jason Abel; Timothy J Ziemlewicz; Sara Best; Meghan G Lubner; Stephen Y Nakada; J Louis Hinshaw; Christopher L Brace; Fred T Lee; Shane A Wells
Journal:  Radiology       Date:  2017-01-11       Impact factor: 11.105

Review 3.  Image-guided ultrasound phased arrays are a disruptive technology for non-invasive therapy.

Authors:  Kullervo Hynynen; Ryan M Jones
Journal:  Phys Med Biol       Date:  2016-08-05       Impact factor: 3.609

4.  Effects of tissue mechanical properties on susceptibility to histotripsy-induced tissue damage.

Authors:  Eli Vlaisavljevich; Yohan Kim; Gabe Owens; William Roberts; Charles Cain; Zhen Xu
Journal:  Phys Med Biol       Date:  2013-12-19       Impact factor: 3.609

5.  High intensity focused ultrasound in clinical tumor ablation.

Authors:  Yu-Feng Zhou
Journal:  World J Clin Oncol       Date:  2011-01-10

6.  Pulsed cavitational ultrasound: a noninvasive technology for controlled tissue ablation (histotripsy) in the rabbit kidney.

Authors:  William W Roberts; Timothy L Hall; Kimberly Ives; J Stuart Wolf; J Brian Fowlkes; Charles A Cain
Journal:  J Urol       Date:  2006-02       Impact factor: 7.450

Review 7.  Imaging appearances at follow-up after image-guided solid-organ abdominal tumour ablation.

Authors:  N Patel; A J King; D J Breen
Journal:  Clin Radiol       Date:  2017-02-23       Impact factor: 2.350

8.  Image-guided non-invasive ultrasound liver ablation using histotripsy: feasibility study in an in vivo porcine model.

Authors:  Eli Vlaisavljevich; Yohan Kim; Steven Allen; Gabe Owens; Shawn Pelletier; Charles Cain; Kimberly Ives; Zhen Xu
Journal:  Ultrasound Med Biol       Date:  2013-05-15       Impact factor: 2.998

Review 9.  Percutaneous ablation for small renal masses-imaging follow-up.

Authors:  Jason D Iannuccilli; David J Grand; Damian E Dupuy; William W Mayo-Smith
Journal:  Semin Intervent Radiol       Date:  2014-03       Impact factor: 1.513

10.  Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline.

Authors:  Sherri M Donat; Mireya Diaz; Jay Todd Bishoff; Jonathan A Coleman; Philipp Dahm; Ithaar H Derweesh; S Duke Herrell; Susan Hilton; Eric Jonasch; Daniel W Lin; Victor E Reuter; Sam S Chang
Journal:  J Urol       Date:  2013-05-07       Impact factor: 7.450

View more
  4 in total

1.  Transcostal Histotripsy Ablation in an In Vivo Acute Hepatic Porcine Model.

Authors:  Emily A Knott; Katherine C Longo; Eli Vlaisavljevich; Xaiofei Zhang; John F Swietlik; Zhen Xu; Allison C Rodgers; Annie M Zlevor; Paul F Laeseke; Timothy L Hall; Fred T Lee; Timothy J Ziemlewicz
Journal:  Cardiovasc Intervent Radiol       Date:  2021-07-09       Impact factor: 2.740

2.  A comparison study of microwave ablation vs. histotripsy for focal liver treatments in a swine model.

Authors:  Emily A Knott; Annie M Zlevor; J Louis Hinshaw; Paul F Laeseke; Colin Longhurst; Jenifer Frank; Charles W Bradley; Allison B Couillard; Annika E Rossebo; Zhen Xu; Fred T Lee; Timothy J Ziemlewicz
Journal:  Eur Radiol       Date:  2022-09-01       Impact factor: 7.034

3.  Impact of Histotripsy on Development of Intrahepatic Metastases in a Rodent Liver Tumor Model.

Authors:  Tejaswi Worlikar; Man Zhang; Anutosh Ganguly; Timothy L Hall; Jiaqi Shi; Lili Zhao; Fred T Lee; Mishal Mendiratta-Lala; Clifford S Cho; Zhen Xu
Journal:  Cancers (Basel)       Date:  2022-03-22       Impact factor: 6.639

4.  Histotripsy: the first noninvasive, non-ionizing, non-thermal ablation technique based on ultrasound.

Authors:  Zhen Xu; Timothy L Hall; Eli Vlaisavljevich; Fred T Lee
Journal:  Int J Hyperthermia       Date:  2021       Impact factor: 3.753

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.